Published By : 13 May 2016 | Published By : QYRESEARCH
The global polycaprolactone market is reporting a significant rise in its market valuation. The soaring demand for polycaprolactone in the paints and coating, medical devices, leather, automotive, and packaging industries has propelled this market significantly in the recent past.
Apart from this, the rising application of polycaprolactone in the production of drug delivery devices and several other medical components such as suture, wound dressing tapes, and dental appliances is likely to boost this market over the next few years.
Europe to Retain Leadership in Global Polycaprolactone Market
Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa are the key regional markets in the worldwide market for polycaprolactone. In 2015, Europe acquired the leadership in the overall market with a share of 28.6% in terms of revenue and 38.1% in terms of value.
The Europe polycaprolactone market is expected to retain its leading position in the coming years in terms of both volume and revenue. Analysts estimate this regional market to rise at a CAGR of around10.5% during the period from 2015 to 2021 in terms of value.
Asia Pacific Market for Polycaprolactone to Report a Volume Rise at 12.0% CAGR between 2015 and 2021
In terms of volume, Asia Pacific occupied the second position in the overall market in 2015 with a total share of 29.5%. This regional market is projected to increase its production volume at a CAGR of 12% between 2015 and 2021.
On the other hand, the markets for polycaprolactone in Latin America and the Middle East and Africa are expected to report a rise in their market values at a CAGR of 9.5% and 10%, respectively, during the same period.
The key players in the worldwide polycaprolactone market are Daicel Corp., Sigma-Aldrich Corp., Durect Corp., Corbion Purec, Shenzhen Esun Industries Co. Ltd., Haihang Industries Co. Ltd., BASF SE, and Perstorp Holding A.B.